Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients	B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease	Recruiting	Not applicable	2026-03-10		NCT06343090

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing GoBroad Hospital	42
Central People's Hospital of Zhanjiang	7
First Affiliated Hospital of Guangxi Medical University	96
Ruijin Hospital	454
Shanghai Liquan Hospital	11
The General Hospital of Western Theater Command	26
Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing GoBroad Hospital	Beijing	China	17